TrialInvestigational new drugs2011

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

Deborah A Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.